In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the ...

Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...

After hours: September 19 at 4:06 PM EDT Loading Chart for LGND ...

These new therapeutic options -- endothelin antagonists, dual angio- tensin-converting enzyme-endopeptidase or vasopeptide inhibitors, and recombinant preparations of human brain natriuretic ...

In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

The green light is also a milestone for Novartis because it marks the first approval in its renal disease pipeline, which includes three therapies for IgAN – Fabhalta, oral endothelin A receptor ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed ...